TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.040
-0.030 (-2.80%)
At close: Mar 19, 2026, 4:00 PM EDT
1.042
+0.002 (0.17%)
After-hours: Mar 19, 2026, 5:51 PM EDT
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $59.18 million as of March 19, 2026. Its market cap has decreased by -45.54% in one year.
Market Cap
59.18M
Enterprise Value
909.69K
1-Year Change
-45.54%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $59.18M, a decrease of -83.52%. That is a compound annual growth rate of -31.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 59.18M | 4.28% |
| Dec 31, 2025 | 56.75M | -66.96% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | 359.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actuate Therapeutics | 64.38M |
| Entera Bio | 64.20M |
| ImageneBio | 64.14M |
| Fractyl Health | 62.93M |
| Coeptis Therapeutics Holdings | 62.48M |
| InflaRx | 61.87M |
| eXoZymes | 61.31M |
| MindWalk Holdings | 61.09M |